Advertisement
Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

15 Periodical Search Results

You searched for "selective" AND "oestrogen" OR "estrogens" OR "oestrogens" OR "estrogenic preparation" OR "oestrogenic preparation" AND "modulators" within Cancer Treatment Reviews

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-15  of 15 results  

Results Page:  [1]

display abstract citation download email a colleague
Display:

  1. Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective , 02 November 2004
    John F.R. Robertson
    Cancer Treatment Reviews
    December 2004 (Vol. 30, Issue 8, Pages 695-706)
    Abstract | Full Text | Full-Text PDF (307 KB)

  1. The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors
    Marzena Welnicka-Jaskiewicz, Jacek Jassem
    Cancer Treatment Reviews
    October 2003 (Vol. 29, Issue 5, Pages 355-361)
    Abstract | Full Text | Full-Text PDF (96 KB)

  1. Management of treatment-related osteoporosis in men with prostate cancer
    Matthew R Smith
    Cancer Treatment Reviews
    June 2003 (Vol. 29, Issue 3, Pages 211-218)
    Abstract | Full Text | Full-Text PDF (103 KB)

  1. The metabolic syndrome in long-term cancer survivors, and important target for secondary preventive measures
    Janine Nuver, Andries J Smit, Aleida Postma, Dirk Th Sleijfer, Jourik A Gietema
    Cancer Treatment Reviews
    August 2002 (Vol. 28, Issue 4, Pages 195-214)
    Abstract | Full Text | Full-Text PDF (213 KB)

  1. The effects of tamoxifen on the female genital tract
    Elżbieta Senkus-Konefka, Tomasz Konefka, Jacek Jassem
    Cancer Treatment Reviews
    May 2004 (Vol. 30, Issue 3, Pages 291-301)
    Abstract | Full Text | Full-Text PDF (215 KB)

  1. Clinical development of fulvestrant (‘Faslodex’) , 04 October 2005
    Anthony Howell, Paul Abram
    Cancer Treatment Reviews
    2005 (Vol. 31Supplement 2, Pages S3-S9)
    Abstract | Full Text | Full-Text PDF (133 KB)

  1. Management of the menopause in cancer survivors
    Mark Clemons, Andrew Clamp, Beverley Anderson
    Cancer Treatment Reviews
    December 2002 (Vol. 28, Issue 6, Pages 321-333)
    Abstract | Full Text | Full-Text PDF (169 KB)

  1. The influence of endocrine treatments for breast cancer on health-related quality of life , 03 June 2008
    Ciska Buijs, Elisabeth G.E. de Vries, Marian J.E. Mourits, Pax H.B. Willemse
    Cancer Treatment Reviews
    November 2008 (Vol. 34, Issue 7, Pages 640-655)
    Abstract | Full Text | Full-Text PDF (205 KB)

  1. Tamoxifen: Important considerations of a multi-functional compound with organ-specific properties , 22 December 2006
    Maneesh N. Singh, Helen F. Stringfellow, Evangelos Paraskevaidis, Pierre L. Martin-Hirsch, Francis L. Martin
    Cancer Treatment Reviews
    April 2007 (Vol. 33, Issue 2, Pages 91-100)
    Abstract | Full Text | Full-Text PDF (1113 KB)

  1. Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies , 20 May 2008
    Robert E. Coleman, Jean-Jacques Body, Julie R. Gralow, Allan Lipton
    Cancer Treatment Reviews
    2008 (Vol. 34Supplement 1, Pages S31-S42)
    Abstract | Full Text | Full-Text PDF (346 KB)

  1. Fulvestrant (‘Faslodex’): Clinical experience from the Compassionate Use Programme , 04 October 2005
    Guenther G. Steger, Maya Gips, Sergio D. Simon, Ana Lluch, Jefferson Vinholes, Bella Kaufman, Andrew Wardley, Louis Mauriac
    Cancer Treatment Reviews
    2005 (Vol. 31Supplement 2, Pages S10-S16)
    Abstract | Full Text | Full-Text PDF (109 KB)

  1. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer , 26 March 2008
    Helen M. Coley
    Cancer Treatment Reviews
    June 2008 (Vol. 34, Issue 4, Pages 378-390)
    Abstract | Full Text | Full-Text PDF (476 KB)

  1. A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer , 23 May 2005
    David Dodwell, Ignace Vergote
    Cancer Treatment Reviews
    June 2005 (Vol. 31, Issue 4, Pages 274-282)
    Abstract | Full Text | Full-Text PDF (317 KB)

  1. Systemic therapy in metastatic or recurrent endometrial cancer , 02 January 2007
    D. Pectasides, E. Pectasides, T. Economopoulos
    Cancer Treatment Reviews
    April 2007 (Vol. 33, Issue 2, Pages 177-190)
    Abstract | Full Text | Full-Text PDF (229 KB)

  1. Switching to exemestane after 2–3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen: Abstracted from: Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081–92.
    Christina Davies
    Cancer Treatment Reviews
    October 2004 (Vol. 30, Issue 6, Pages 583-588)
    Full Text | Full-Text PDF (248 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-15  of 15 results  

Results Page:  [1]

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement

Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.